Bravo PE - Search Results

1

Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP. Bravo PE, et al. J Nucl Cardiol. 2016 Dec;23(6):1304-1314. doi: 10.1007/s12350-015-0158-8. Epub 2015 May 20. J Nucl Cardiol. 2016. PMID: 25989730

2

Reference ranges for LVEF and LV volumes from electrocardiographically gated 82Rb cardiac PET/CT using commercially available software.

Bravo PE, Chien D, Javadi M, Merrill J, Bengel FM. Bravo PE, et al. J Nucl Med. 2010 Jun;51(6):898-905. doi: 10.2967/jnumed.109.073858. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484424 Free article.

3

Human biodistribution and radiation dosimetry of 82Rb.

Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM. Senthamizhchelvan S, et al. Among authors: bravo pe. J Nucl Med. 2010 Oct;51(10):1592-9. doi: 10.2967/jnumed.110.077669. Epub 2010 Sep 16. J Nucl Med. 2010. PMID: 20847168 Free PMC article.

4

Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.

Higuchi T, Fukushima K, Xia J, Mathews WB, Lautamäki R, Bravo PE, Javadi MS, Dannals RF, Szabo Z, Bengel FM. Higuchi T, et al. Among authors: bravo pe. J Nucl Med. 2010 Dec;51(12):1956-61. doi: 10.2967/jnumed.110.079855. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078800 Free article.

5

Radiation dosimetry of 82Rb in humans under pharmacologic stress.

Senthamizhchelvan S, Bravo PE, Lodge MA, Merrill J, Bengel FM, Sgouros G. Senthamizhchelvan S, et al. Among authors: bravo pe. J Nucl Med. 2011 Mar;52(3):485-91. doi: 10.2967/jnumed.110.083477. Epub 2011 Feb 14. J Nucl Med. 2011. PMID: 21321275 Free PMC article.

6

Washout of ⁸²Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability.

Chien DT, Bravo P, Higuchi T, Merrill J, Bengel FM. Chien DT, et al. Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1507-15. doi: 10.1007/s00259-011-1820-2. Epub 2011 Apr 29. Eur J Nucl Med Mol Imaging. 2011. PMID: 21528386

7

The role of cardiac PET in translating basic science into the clinical arena.

Bravo PE, Bengel FM. Bravo PE, et al. J Cardiovasc Transl Res. 2011 Aug;4(4):425-36. doi: 10.1007/s12265-011-9285-z. Epub 2011 May 15. J Cardiovasc Transl Res. 2011. PMID: 21573964 Review.

8

Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.

Goudarzi B, Fukushima K, Bravo P, Merrill J, Bengel FM. Goudarzi B, et al. Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1908-16. doi: 10.1007/s00259-011-1853-6. Epub 2011 Jun 9. Eur J Nucl Med Mol Imaging. 2011. PMID: 21656246

9

PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.

Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, Abraham MR, Wahl RL, Abraham TP, Bengel FM. Bravo PE, et al. J Nucl Med. 2012 Mar;53(3):407-14. doi: 10.2967/jnumed.111.096156. Epub 2012 Feb 7. J Nucl Med. 2012. PMID: 22315440 Free article.

10

Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker.

Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, Bravo PE, Bengel FM. Rischpler C, et al. Among authors: bravo pe. J Nucl Med. 2012 May;53(5):723-30. doi: 10.2967/jnumed.111.097600. Epub 2012 Apr 9. J Nucl Med. 2012. PMID: 22492731 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters